{
  "context": {
    "rules": [
      "Rule1: Provided that substance X has been researched, then it follows that it is beneficial to patients.",
      "Rule2: Whenever substance X is withdrawn from market, then device W does not require modification.",
      "Rule3: If substance X passes safety test, then it is beneficial to patients.",
      "Rule4: Under the condition that substance X shows promise, then it is beneficial to patients.",
      "Rule5: Either substance X completes phase II or it enters phase III.",
      "Rule6: If substance X enters phase III, then it shows promise.",
      "Rule7: Whenever substance X generates revenue, then it achieves commercial success.",
      "Rule8: Provided that substance X demonstrates cost effectiveness, then project P attracts investment.",
      "Rule9: Substance X demonstrates cost effectiveness or it faces regulatory hurdles.",
      "Rule10: Under the condition that substance X improves patient outcomes, then it does not achieve commercial success.",
      "Rule11: Provided that it reduces symptoms of disease D, then substance X improves patient outcomes.",
      "Rule12: It reduces symptoms of disease D or it prevents progression of disease D.",
      "Rule13: If study results create confusion, then they provide clarity.",
      "Rule14: Under the condition that study results contain contradictions, then if they create confusion, they do not provide clarity.",
      "Rule15: Study results contain contradictions or they have methodological flaws.",
      "Rule16: Provided that study results need replication, then if they create confusion, they do not provide clarity.",
      "Rule17: If it was approved by the FDA agency, then substance X causes side effects.",
      "Rule18: It was approved by the FDA agency or if it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z.",
      "Rule19: Provided that it treats disease D, then if it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring.",
      "Rule20: Substance X shows efficacy or if it is not the case that it is beneficial to patients then it does not exhibit toxicity.",
      "Rule21: If it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W requires modification.",
      "Rule22: Provided that it is not the case that either substance X fails clinical trial or it does not show efficacy, then it is withdrawn from market.",
      "Rule23: If it is not the case that if substance X completes phase II then it passes safety test, then project P receives funding.",
      "Rule24: Whenever it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W undergoes review.",
      "Rule25: If it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W does not undergo review.",
      "Rule26: Provided that it is not the case that if it prevents progression of disease D then substance X improves patient outcomes, then study results create confusion.",
      "Rule27: Under the condition that it is not the case that if study results have methodological flaws then they need replication, then they require peer review.",
      "Rule28: If it is not the case that if study results have methodological flaws then they need replication, then they do not require peer review.",
      "Rule29: Whenever it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W does not require monitoring.",
      "Rule30: If it is not the case that if it is not the case that if substance X completes phase II then it passes safety test then project P does not receive funding, then substance X generates revenue.",
      "Rule31: Under the condition that it is not the case that if substance X was not researched then it was published on platform Y, then it was not tested on animal model Z.",
      "Rule32: Provided that it is not the case that substance X is beneficial to patients, then it exhibits toxicity."
    ],
    "facts": [
      "Fact1: It treats disease D.",
      "Fact2: It is not the case that substance X fails clinical trial.",
      "Fact3: It is not the case that project P attracts investment.",
      "Fact4: It is not the case that the research was published on platform Y."
    ]
  },
  "question": "Substance X is beneficial to patients."
}